Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
BioStem Technologies, Inc. (BSEM) had Normalized Income after Taxes of $-8.97M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$7.90M |
|
$-8.97M |
|
$3.06M |
|
$4.84M |
|
$16.30M |
|
$-8.40M |
|
$-0.57M |
|
$-8.97M |
|
$-8.97M |
|
$-8.97M |
|
$-8.97M |
|
$-8.97M |
|
|
Normalized Income after Taxes |
$-8.97M |
$-8.40M |
|
$-8.40M |
|
17.33M |
|
17.33M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$20.78M |
|
$9.85M |
|
$32.96M |
|
$48.82M |
|
$21.20M |
|
-- |
|
$0.00M |
|
$21.20M |
|
$27.61M |
|
$4.72M |
|
$27.61M |
|
17.84M |
|
| Cash Flow Statement Financials | |
$-6.36M |
|
$-15.08M |
|
$-1.15M |
|
$29.55M |
|
$6.96M |
|
$-22.59M |
|
$3.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.98 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
61.28% |
|
-106.35% |
|
-106.35% |
|
-- |
|
-113.57% |
|
-113.57% |
|
$-6.42M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.65 |
|
1.19 |
|
75.44 |
|
-32.49% |
|
-189.96% |
|
-18.38% |
|
-32.49% |
|
$1.55 |
|
$-0.37 |
|
$-0.37 |
|